ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Seminar 2013 - 2-day In-person Seminar on Software Validation for the New FDA inspections at San Diego

Date2013-09-12 - 2013-09-13

Deadline2013-09-12

VenueDoubletree Hotel San, USA - United States USA - United States

KeywordsDevice History File, Iso 13485; Compliance Training; USA Seminars,HIPAA Privacy

Websitehttps://bit.ly/15QcPyJ

Topics/Call fo Papers

Overview:
One of our most popular subjects, continuously updated with the latest U.S. FDA and European Union requirements. As U.S. companies go global, they must meet different product design documentation. The U.S. FDA's CGMPs mandate Design Control and the Design History File (DHF) at 21 CFR 820.30. In order to sell globally, the EU's CE-marking documentation is a requirement -- the Technical FiIe or Design Dossier, as described in their Medical Device Directive. What are the requirements for each file? Currently they serve different purposes, support different goals, but the TF/DD is moving in the direction of the DHF. And the DHF is adapting to some of the features of the TF/DD. And how / where do the DMR and DHR fit? Being aware of the required content, as well as the similarities and differences in the files and their individual documents can further concurrent development and/or updates to both.
Why should you attend?
This seminar /workshop will examine the existing and proposed requirements for the U.S. FDA's DHF -- including its derivative documents, the DMR and DHR. It will consider the European Union's MDD TF/DD requirements, and evaluate the documents' differing purposes / goals, their similarities, as well as the two different device classification schemes. Required and desirable contents will be discussed. Also considered: Areas requiring frequent re-evaluation / update; Similarities and differences; Future trends; Typical DHF Table of Contents; Technical File or Design Dossier Table of Contents; The importance and usefulness of the "Essential Requirements"; Structure of the "Declaration of Conformity"; self-declaring or Notified-Body reviewed; Parallel approaches to development. Finally, the differing approaches to file audits by the U.S. FDA and the EU Notified Body will be discussed.
Course Outline:
Day 1 ? 12th September 2013
Lecture 1: The Design Control requirements of the CGMPs, 21 CFR 820.30
Lecture 2: The Design History File - documenting Product Design Control and its nine elements
Lecture 3: The Device Master Record and the Device History Record
Lecture 4: Summary of morning discussion
Lecture 5: Group activity on the 1) The DHF, or 2) The DMR and DHRs
Lecture 6: Review of group activity and Q&A
Day 2 - 13th September 2013
Lecture 7: The EU's Medical Device Directive
Lecture 8: The "Essential Requirements" and their documentation
Lecture 9: The remaining elements of a Technical File / Design Dossier
Lecture 10: ISO 14971:2012, The Product Risk Management File / Report overview
Lecture 11: DHF / TF, DD Trends
Lecture 12: Summary of morning discussion
Lecture 13: Group activity on 1) The Technical File / Design Dossier, or 2) Essential Requirements
Lecture 14: Review of group activity and Q&A
Lecture 15: Summary of morning discussion
Lecture 16: Course summary discussion
Who Will Benefit:
This workshop will provide valuable assistance to all regulated companies that need to implement, review and/or modify their Device History Files, Device Master Records, Device History Records, Technical Files / Design Dossiers, documents, activities / plan(s). This information addresses Medical Device documentation requirements and implementation. The employees who will benefit include:
? Senior and middle management and staff
? Regulatory Affairs
? QA/QC
? R&D
? Production Management
? Manufacturing Engineers
? Process Engineers
? Project Managers
? Vendors, sales and marketing
? Any tasked with medical device development, documentation, and regulatory responsibilities
About Speaker: John E. Lincoln is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 31 years’ experience in U.S. FDA-regulated industries, 17 of which as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment V&V including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).
DATE, VENUE & PRICE:
Las Vegas | September 12th & 13th, 2013 | 9 AM to 6 PM
Hotel: Hilton Grand Vacations Suites at the Flamingo
Address: 3575 Las Vegas Boulevard South, Las Vegas, Nevada, 89109-4313, USA
Price: $1,295.00
Register now and save $200. (Early Bird)
Until March 29, Early Bird Price: $1,295.00
from March 30 to April 30, Regular Price: $1,495.00
Contact Information:
Event Coordinator
Toll free: 1800 447 9407
Fax: 302 288 6884
Email: support-AT-globalcompliancepanel.com
Website: https://www.globalcompliancepanel.com
Event Link: http://bit.ly/14Yo5cG
LIVE CHAT SUPPORT ALSO - http://www.globalcompliancepanel.com/chat/client.p...
Net Zealous LLC, DBA GlobalCompliancePanel
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA

Last modified: 2013-08-06 22:15:07